COPOLAD III Technical Committee meeting
The EMCDDA is hosting a COPOLAD III Technical Committee meeting on 2-3 March, attended by representatives of the International Ibero-American Foundation for Public Policies and Administrations (FIIAPP), the Italian-Latin American International Organization (IILA) and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ).
Over the two days, the Committee members and EMCDDA staff will be discussing COPOLAD III achievements to date and the workplan for 2023, including the outputs and activities to be delivered by the agency under the grant agreement signed in 2022.
The EMCDDA became an official partner of COPOLAD III in July 2022. The programme promotes dialogue and bi-regional cooperation on drug policy between the European Union and Latin American and Caribbean countries. Funded by the EU, the programme is led by FIIAPP, in consortium with IILA. The EMCDDA and GIZ also collaborate in the programme.
The current 32 project partners are: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominica, El Salvador, Ecuador, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Panama, Paraguay, Peru, Dominican Republic, Saint Lucia, Saint Kitts and Nevis, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Venezuela, Uruguay.